youtube_live
Q3 2026 earnings • released • EPS beat +११.३८% • Revenue beat +७.३३%
See resultschevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ ३१.००
arrow_upward
+५.३९%(+१.५९) 1D
नोभेम्बर ९, १३:५३:४१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २९.३२
High
US$ ३१.१०
Low
US$ २८.९३
Mkt. cap
१.८५ अरब
Avg. vol.
१२.९३ लाख
Volume
४.४४ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ७.०१
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २९.३२
High
US$ ३१.१०
Low
US$ २८.९३
Mkt. cap
१.८५ अरब
Avg. vol.
१२.९३ लाख
Volume
४.४४ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ७.०१
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
ChartMill
·
१ घण्टा पहिले
S&P 500 Top Movers: Today's US Session Gainers and Losers
Yahoo Finance
·
१ घण्टा पहिले
S&P 500 Just Wiped Out $3 Trillion: Why This 0.35-Beta Stock is a Safe Haven
Quartz
·
४ घण्टा पहिले
Morgan Stanley says S&P 500 correction is nearing an end, with a likely year-end rally ahead
StoneX
·
२ घण्टा पहिले
S&P 500 Forecast: SPX rises despite Nvidia’s decline
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc